DermTech Inc - SIC # 8734 - TESTING LABORATORIES

Ticker Exchange SIC # Website Latest Ticker
DMTK Nasdaq 8734 http://www.constellationalpha.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for DermTech Inc

Cancer test maker Dermtech to cut 100 jobs, explore strategic options - Apr 19th, 2024 3:42 pm
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan - Apr 18th, 2024 8:15 pm
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Apr 1st, 2024 8:05 pm
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology - Mar 8th, 2024 1:05 pm
DermTech, Inc. (NASDAQ:DMTK) Analysts Are Cutting Their Estimates: Here's What You Need To Know - Mar 3rd, 2024 12:34 pm
DermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcript - Mar 2nd, 2024 1:34 pm
DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates - Feb 29th, 2024 10:25 pm
DermTech Reports Fourth-Quarter 2023 Financial Results - Feb 29th, 2024 9:01 pm
DermTech Announces Release Date for Fourth-quarter 2023 Financial Results - Feb 13th, 2024 1:05 pm
DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations - Jan 31st, 2024 9:30 pm
DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types - Jan 18th, 2024 1:05 pm
DermTech (NASDAQ:DMTK) Will Have To Spend Its Cash Wisely - Jan 16th, 2024 1:33 pm
DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay - Jan 16th, 2024 1:05 pm
DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT) - Jan 8th, 2024 1:00 pm
DermTech, Inc. (NASDAQ:DMTK) Q3 2023 Earnings Call Transcript - Nov 3rd, 2023 1:35 pm
DermTech Inc (DMTK) Reports 10% Increase in Total Revenue for Q3 2023 - Nov 2nd, 2023 9:47 pm
DermTech Reports Third-Quarter 2023 Financial Results - Nov 2nd, 2023 8:01 pm
DermTech Announces Release Date for Third-Quarter 2023 Financial Results - Oct 12th, 2023 12:05 pm
DermTech Grants New CCO Mark Aguillard Inducement Award Under NASDAQ Listing Rule 5635(c)(4) - Sep 21st, 2023 8:05 pm
DermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT) - Sep 19th, 2023 12:05 pm